Evidence map›Paper›PMID 41425970›Full record

ArticleBJR case reports2025

Peritoneal metastases from colorectal cancer managed by stereotactic body radiation therapy: presentation of a clinical case and review of literature.

Alexander Bennassi, Stanislas Ropert, Gokoulakrichenane Loganadane, Clarisse Dromain, Toufik Bennassi

Abstract readCase Reports
In one paragraph

Article in BJR case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander BennassiDepartment of Radio-Oncology, Centre de Cancérologie de Thiais, Thiais 94320, France.ORCID https://orcid.org/0000-0002-6443-6693
Stanislas RopertDepartment of Oncology, Hôpital Privé d'Antony, Antony 92160, France.
Gokoulakrichenane LoganadaneDepartment of Radiation Oncology, Institut Curie, Paris 75005, France.ORCID https://orcid.org/0000-0001-5888-8688
Clarisse DromainDepartment of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne 1011, Switzerland.
Toufik BennassiDepartment of Radio-Oncology, Centre de Cancérologie de Thiais, Thiais 94320, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peritoneal metastasis (PM, or peritoneal carcinomatosis) is often associated with dismal prognosis. The treatment of peritoneal metastasis depends on several factors, including the type of primary cancer, the extent of metastasis and the patient's overall health condition. Apart from systemic chemotherapy and cytoreductive surgery (CRS), locoregional therapies such as hyperthermic intraperitoneal chemotherapy (HIPEC) or pressurized intraperitoneal aerosol chemotherapy (PIPAC) may improve tumour control. CRS is a complex procedure with high morbidity, performed only in approximately 25% of all eligible patients and the efficiency of other non-surgical therapies is not well known. The place of radiation therapy needs to be defined. A 62-year-old woman was referred for surgery for a few days' history of large bowel obstruction. A previous abdominopelvic CT showed an obstructive 3-cm mass in the proximal ascending colon, associated with small bowel dilatation. Right hemi-colectomy was performed. Work-up demonstrated on MRI (magnetic resonance imaging) sub-centimetric secondary liver lesions.

Indexed as

oligorecurrentperitoneal metastasesstereotactic body radiation therapy

Identifiers

PMID41425970
PMCPMC12718100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.